Student Spotlight


Hieu Hoang

Thesis Title: Identifying chemoreceptors important for sperm guidance in C. elegans
Mentor: Michael A. Miller, PhD
Department: Cell, Developmental and Integrative Biology
Undergrad: BS, San Jose State University

Welcome to the Cell, Molecular, and Developmental Biology (CMDB) PhD Theme, a part of the Graduate Biomedical Sciences program at the University of Alabama at Birmingham School of Medicine. The CMDB theme is designed to provide maximum flexibility that results in students who are prepared to launch into a career in the emerging biomedical science field. Our graduates have exciting careers in scientific research in both academic and industrial settings; scientific-related writing, business, law, bioterrorism, forensics, administration, and education. 

About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.

About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.

Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
No events found
  • Gift of $500,000 by leader in the dental lab industry includes computer-aided design and computer-aided manufacturing software for milling dental prostheses and completing restorations.Winstead and family stand together during the new lab's dedication.The University of Alabama at Birmingham’s School of Dentistry dedicated the new D. Thomas Winstead Student Laboratory on Thursday, April 30, giving students and patients a new, cutting-edge technological dental space to enhance training and care. The lab was completed thanks in part to a $500,000 contribution from Winstead, who is president and CEO of Oral Arts Dental Laboratories in Huntsville and has a relationship with the UAB School of Dentistry that dates back to the 1970s. Oral Arts has donated special equipment to the school on numerous occasions and helped arrange important educational events that benefit both students and alumni. The school has been raising funds to renovate the third-floor student lab space for several years through its class...

  • The protective effect is achieved by reducing acute inflammation in the spleen and the left ventricle of the heart.Ganesh HaladeChronic inflammation provokes a downward spiral in many diseases, including congestive heart failure, atherosclerosis and peripheral artery disease. A University of Alabama at Birmingham-led research team has now found that mice that are given the lipid “Resolvin D1” after experimental heart attacks have substantially reduced amounts of inflammation and heart failure. “Thus, Resolvin D1 has the potential to delay heart failure but still requires long-term studies in order to prove its utilization in chronic heart failure management,” Ganesh Halade, Ph.D., and his study co-authors concluded in a Journal of Molecular and Cellular Cardiology article recently published online. “This paper is the first to show resolvin’s effect on heart failure,” said Halade, an assistant professor in the Division of Cardiovascular Disease, UAB Department of Medicine. About 5.1 million people in the United States have...

  • UAB gets $11 million grant for potential groundbreaking study of beta blockers for patients with COPD.Researchers at the University of Alabama at Birmingham will lead a multisite study of the role of beta blockers in patients with chronic obstructive pulmonary disease, or COPD. The study is funded by an $11 million grant from the United States Department of Defense. COPD is the third leading cause of death in the United States and is among the most costly chronic illnesses in terms of total medical spending, missed work and disability. While it is primarily a lung disease that causes difficulty in breathing, patients with COPD are also at risk for heart disease. Beta blockers, commonly used to treat heart disease, are often not used in patients who also have COPD because of safety concerns. “Many physicians have been reluctant to prescribe beta blockers for patients who also have COPD due to concerns that...

Epi Menu